UK Renal Registry 16th Annual Report Figure 13.1. Median height z-scores for transplant patients <16 years in 2012.

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 9 th Annual Report 2006 Fig 13.1 ERF patients below 15 years of age, by year of data collection.
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.
UK Renal Registry 13th Annual Report
UK Renal Registry 18th Annual Report
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
CHAPTER 5 Paediatric Renal Replacement Therapy
UK Renal Registry 13th Annual Report
ANZDATA 2014 Annual Report Chapter 11
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Cystic Fibrosis Registry Annual Data Report 2017
UK Renal Registry 16th Annual Report
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
UK Renal Registry 9th Annual Report 2006
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median weight z-scores for transplant patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median BMI z-scores for transplant patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median height z-scores for dialysis patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median weight z-scores for dialysis patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median BMI z-scores for dialysis patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure BMI categorisation in children <16 years by modality in 2012

UK Renal Registry 16th Annual Report Figure Use of growth hormone in children <16 years with a height under 2SD in the UK between 2001 and 2012

UK Renal Registry 16th Annual Report Figure Median systolic blood pressure z-scores for transplant patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure Median systolic blood pressure z-scores for dialysis patients <16 years in 2012

UK Renal Registry 16th Annual Report Figure The percentage of patients <16 years achieving the treatment standard for haemoglobin between 2001–2012, by treatment modality

UK Renal Registry 16th Annual Report Figure The achievement of haemoglobin treatment standards in paediatric transplant patients <16 years, by the level of graft function This figures combines all data from 2001–2012.

UK Renal Registry 16th Annual Report Figure The achievement of haemoglobin treatment standards in paediatric transplant patients <16 years, by use of MMF between 2001–2012

UK Renal Registry 16th Annual Report Figure The use of erythropoietin and IV iron in paediatric patients <16 years between 2001 and 2012 by treatment modality